Victoria Diartt, APRN, Aesthetic Medicine & Dermatology Specialist Clinical Evidence: What the Studies Show Citation: Yoo PY, Sim WY, Lee Y, Lee SY
The good fats are essential to build healthy cell membranes around the liver cells
Amylin/Calcitonin Receptor Agonism (cagrilintide) Delays gastric emptying, reduces postprandial glucagon, and strongly promotes satiety Modulates appetite-regulating centers in the hindbrain, hypothalamus, and brain reward circuits, directly influencing food intake and choice May transiently activate the renin-angiotensin-aldosterone system with dose escalation, but without blood pressure or electrolyte derangements GLP-1 Receptor Agonism (semaglutide) Stimulates glucose-dependent insulin secretion and suppresses glucagon release to improve glycemic control Reduces appetite and ad libitum energy intake, with central effects on GLP-1R-expressing nuclei in hypothalamus and brainstem Delays gastric emptying and increases satiety, contributing to progressive bodyweight loss Pharmacokinetic Profile Route of Administration Subcutaneous Dosing Frequency Once weekly Route of Administration : Subcutaneous Injection Dosing Frequency: Once weekly Half -life: Cagrilintide: 7-8 days
She is the best
The intervals between injections can differ based on: Absorption Capacity: If you have impaired absorption, such as in pernicious anemia, our healthcare providers may suggest more frequent injections, potentially even on a weekly basis
